Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Amiloride Clinical Trial in Optic Neuritis
ISRCTN99153976Phase 2Completed
- Sponsor
- University of Oxford
- Start
- Mar 2013
- Modality
- Small Molecules
01
Overview
Phase 2, randomised, double-blind trial in optic neuritis (ON) comparing Amiloride with Placebo (2 arms). Primary endpoint: Retinal fibre layer thickness by scanning laser polarimetry at 12 months. Started Mar 2013; status: completed.
02
Drugs
amiloride
03
Conditions
optic neuritis (ON)
Beyond the preview
Go deeper on ISRCTN99153976.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN99153976.